Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer
S Chatterji, JM Niehues, M van Treeck… - NPJ Breast …, 2023 - nature.com
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …
[HTML][HTML] A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …
ordinated multi-centre approach, we present the first large scale biomarker study to define …
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
MM Hefti, R Hu, NW Knoblauch, LC Collins… - Breast Cancer …, 2013 - Springer
Introduction Estrogen receptor (ER) and progesterone receptor (PR) testing are performed in
the evaluation of breast cancer. While the clinical utility of ER as a predictive biomarker to …
the evaluation of breast cancer. While the clinical utility of ER as a predictive biomarker to …
Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database
WF Anderson, KC Chu, N Chatterjee… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: Hormone receptor expression (presence-positive or absence-negative) may
reflect different stages of one disease or different breast cancer types. Determining whether …
reflect different stages of one disease or different breast cancer types. Determining whether …
A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival
Estrogen signaling plays an essential role in breast cancer progression, and estrogen
receptor (ER) status has long been a marker of hormone responsiveness. However, ER …
receptor (ER) status has long been a marker of hormone responsiveness. However, ER …
[HTML][HTML] Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer
M Callari, V Cappelletti, L De Cecco, V Musella… - Breast cancer research …, 2011 - Springer
Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical
management is based on results obtained from randomized trials conducted in women …
management is based on results obtained from randomized trials conducted in women …
[HTML][HTML] Reproductive history and risk of three breast cancer subtypes defined by three biomarkers
Breast cancer subtypes defined by estrogen receptor (ER), progesterone receptor (PR), and
HER2 expression are biologically distinct and thus, may have distinct etiologies. In …
HER2 expression are biologically distinct and thus, may have distinct etiologies. In …
Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study
A Nounu, SP Kar, CL Relton, RC Richmond - Breast Cancer Research, 2022 - Springer
Background Breast cancer (BC) has the highest cancer incidence and mortality in women
worldwide. Observational epidemiological studies suggest a positive association between …
worldwide. Observational epidemiological studies suggest a positive association between …
Expression-and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
Background Although several transcriptome-wide association studies (TWASs) have been
performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS …
performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS …
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Purpose Androgen receptor (AR) expression is absent in 40–90% of estrogen receptor (ER)-
negative breast cancers. The prognostic value of AR in ER-negative patients and …
negative breast cancers. The prognostic value of AR in ER-negative patients and …
相关搜索
- breast cancer receptor status
- breast cancer steroid hormones
- breast cancer biological differences
- molecular features breast cancers
- breast cancer tumor variants
- breast cancer transcriptional fingerprint
- breast cancer matched cases
- breast cancer white patients
- breast cancer surveillance epidemiology
- breast cancer estrogen receptor
- androgen receptor breast cancers
- breast cancer patient survival